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Summary The study was originally set up to measure accurate cell kinetic parameters in two murine
squamous cell carcinomas (scc) for comparison with radiobiological data on proliferation during radiotherapy.
The tumours, AT84 and AT478, were both moderately well differentiated aneuploid scc. In the course of the
study, several comparisons of techniques were made in two different centres. This paper reports on the results
of those comparisons involving two different detection methods (flow cytometry and immunohistochemistry),
single vs double labelling, and in vivo and in vitro labelling, the latter using tissue slices incubated under high
pressure oxygen. Pulse labelling studies with bromodeoxyuridine (BrdUrd) showed that the labelling indices
(LI) were not significantly different after in vitro or in vivo labelling. In addition, the flow cytometry (FCM)
and immunohistochemistry (IHC) methods also gave labelling indices which were not significantly different.
Only tumour cells were analysed in these studies by selecting cells on the basis of aneuploidy (FCM) or
morphology (IHC). The DNA synthesis time of the tumour cells were analysed by both techniques. For FCM,
the Relative Movement method was used (Begg et al., 1985). For IHC, a double labelling method was used,
employing BrdUrd and triated thymidine ('H-TdR) administered several hours apart, detected simultaneously
using immunoperoxidase and autoradiography, respectively. When both labels were administered in vivo, there
was good agreement for T, between the FCM and IHC methods. Attempts were also made to measure Ts in
vitro using both techniques. With double labelling, it was found that cells did not take up the second label,
implying a failure of cycle progression. This was confirmed by FCM results, showing no movement of labelled
cells through the S-phase, despite an initially high uptake. This could not be influenced by lowering the DNA
precursor concentration or by adding foetal calf serum. This indicates that DNA synthesis times are difficult
or impossible to measure in vitro in fresh tumour explants. Finally, the double labelling IHC method allowed
intratumoural variations of both LI and T, to be studied. Both parameters were found to vary markedly
throughout the tumour volume, particularly for larger tumours (600 mg), giving calculated local potential
doubling time values (Tpo) ranging from 1-7 days.
Tumour cell kinetic studies are not only essential in inves-
tigating the many factors regulating proliferation but have
also been shown to be useful for predicting the response to
therapy (Silvestrini et al., 1984; Tubiana et al., 1989; Begg et
al., 1992; Begg, 1993). Most cell kinetic studies have been
carried out using either radio-labelled thymidine or a
thymidine analog, which are incorporated into cells undergo-
ing DNA synthesis. Such labelling of S-phase cells can be
carried out in vivo or in vitro. In patients, administration of
radiolabelled DNA precursors is precluded because of radia-
tion hazards. Consequently, clinical studies have employed
labelling of biopsy material in vitro (Silvestrini et al., 1984;
Tubiana et al., 1989; Meyer et al., 1986) or administering
non-radioactive thymidine analogs (Begg et al., 1992).
Several questions arise concerning such studies. The first is
whether in vitro labelling is a reasonable substitute for in vivo
labelling. The latter is not without potential risk, since the
thymidine analogs used, iodo- and bromodeoxyuridine
(BrdUrd and IdUrd), are known mutagens although admini-
stered in low doses. In vitro labelling avoids such patient risk
but includes potential artifacts involved in explanting tumour
cells out of their natural environment. In addition, in vitro
labelling requires immediate processing of tumour samples,
while biopsies taken after in vivo labelling can be stored and
analysed where and whenever is convenient. A related ques-
tion is whether it is possible to measure, in vitro, not just the
labelling index (LI; fraction of labelled cells) but also the
DNA synthesis time, Ts. It has been shown possible to
measure T, in vivo with one sample using thymidine analogs
and flow cytometry (FCM), and various techniques for the
analysis of such data have been developed (Begg et al., 1985;
White et al., 1991), allowing the tumour potential doubling
time Tpo, to be estimated. If Ts could also be measured in
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vitro in explanted biopsy material, Tpot could be estimated
from purely in vitro data. A third question concerns the
method of detection of the incorporated DNA precursor. Do
immunohistochemical methods with thymidine analogs
(equivalent to autoradiography with radiolabelled thymidine)
have any advantage over FCM methods? FCM allows the
quantitative measurement per cell of at least two parameters
simultaneously, e.g. total DNA and BrdUrd incorporation.
Immunohistochemistry (IHC) signals are inherently more
difficult to quantify, but have the advantage of retaining
positional and histological information.
The original goal of these studies was to measure
accurately the cell kinetic parameters in two murine tumours
for correlations with radiobiological characteristics of tumour
proliferation during radiotherapy (Kummermehr, 1993).
The radiobiological data were available for tumours at two
sizes, necessitating kinetic measurements at both these sizes.
It was planned to use both FCM and IHC methods to ensure
an accurate and correct description of the cell kinetics. The
study was then also used to attempt to answer the questions
posed above in these two well described animal tumour
models. It thus provides comparisons of FCM and IHC
methods, in vitro with in vivo labelling, single vs double
labelling, the magnitude of intratumoural variations in
kinetic parameters, in addition to the influence of tumour
size.
Materials and methods
Tumours and tumour growth rate
AT84 and 478 are both fairly well differentiated murine
squamous cell carcinoma lines, derived from spontaneous
tumours of the oral and vaginal mucosa respectively. An
early, more slowly growing (AT478/4) and a late, much faster
(AT478/25) generation of one tumour line were compared.
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One mm3 fragments of donor tumour were transplanted
subcutaneously under pentobarbital anaesthesia into the
flank of syngenic Neuherberg C3H mice using a trochar.
Tumour growth was followed by caliper measurements and
volume doubling times were estimated by fitting a Gompertz
growth curve to the measured data.
Labelling with DNA precursors
For in vivo labelling, i.p. injections of 2 mCi kg-' 3H-TdR
(H-5-methyl Thymidine, specific activity 185 MBq mmol 1,
Code No. TRA 61, Amersham Buchler, Braunschweig, Ger-
many) or 50mgkg-' BrdUrd (bromo-deoxyuridine, Sigma)
diluted in saline to a volume of 0.1-0.2ml were given per
mouse.
For in vitro labelling, tumour slices of 0.3 mm were
incubated with 0.4 iJM 3H-TdR or 50pJM BrdUrd in Eagle
medium at 37°C and at 2 atm 02 pressure for 1 h. According
to studies of Boswald et al., 1990, this incubation period was
chosen as equivalent to the in vivo availability time of tracers
given by i.p. injection. The problem of reduced precursor
uptake in the depth of tissue blocks (Denekamp & Kallman
1973; Chavaudra et al., 1979) was successfully circumvented
by incubating very thin tissue slices. In order to exclude toxic
effects, BrdUrd concentrations of 50JAM and 1 JAM were com-
pared in one experiment.
Detection oflabelled cells
Flow cytometry (FCM) In order to estimate Ts, BrdUrd
was injected 1-4 h before tumour excision. Tumours were
then excised, cut into several pieces and dropped into cold
70% ethanol. Fixed tumour pieces were stored at 4°C in the
dark until staining. Tissue preparation and staining for flow
cytometry has been described previously (Begg et al., 1988).
Briefly, the fixed tumour pieces were cut into smaller pieces
and incubated in a pepsin solution to produce a suspension
of nuclei. This was followed by partial acid denaturation of
DNA, incubation with a mouse monoclonal antibody specific
for DNA-incorporated BrdUrd, incubation with an FITC-
conjugated anti-mouse antibody and addition of propidium
iodide (PI) and RNase to stain total DNA. Flow cytometry
was carried out using a FACStar flow cytometer (Becton
Dickinson, Belgium) using excitation at 488 nm and collec-
ting the green (FITC; BrdUrd) and red (PI; DNA) fluor-
escence signals using the following filters: 515-545 nm band
pass (green), 650 nm long pass (red).
Immunohistochemistry (IHC) Two to four neighbouring,
equatorial slices of 0.8 mm thickness were fixed in 2%
paraformaldehyde in phosphate buffer, washed overnight in
6.8% sucrose in phosphate buffer and then embedded into
glycolmethacrylate (Technovit 8100) as previously described
(Schultz-Hector & Haghayegh, 1993). Three ym tissue sec-
tions were mounted on poly-L-lysine coated slides. Labelled
nuclei were visualised by 3H-TdR autoradiography, BrdUrd-
immunohistochemistry, or by combination of both. For
double staining, protease treatment with 0.1% trypsin in
0.1% CaCI2 at ph 7.8 for 10 min at 37°C, followed by 0.4%
pepsin in 0.01 MHCI for 60 min at 37°C was performed
before autoradiography. Slides were then coated with Kodak
NTB 2 nuclear track emulsion diluted at 1:3 with distilled
water. After exposure for 10 days at 4°C in the dark,
autoradiographs were developed. In order to make the
autoradiographic coating permeable for antibodies, slides
were then dipped for 25 s into 0.2% trypsin in PBS at ph 7.2.
Following DNA denaturation by 2 M HCI for 40 min, sec-
tions were incubated for 20 min with normal goat serum
1:20, for 2 h with mouse-anti-BrdUrd 1:40 (37°C), for 30 min
with goat-anti-mouse 1:20 and finally for 30 min with
alkaline-phosphatase-anti-alkaline-phosphatase (APAAP)
complex. The alkaline phosphatase reaction was carried out
using a naphthol AS-Bi-phosphate as substrate and new
fuchsin as chromogen. All antibodies were obtained from
DAKO (DAKO, Hamburg, Germany) and were diluted in
1% bovine serum albumin solution in PBS. Nuclei were
counterstained with haematoxilin and sections coverslipped
with gelatin. If not specified otherwise, reactions were carried
out at room temperature.
Pilot experiments indicated that the double staining proce-
dure as described did not modify the labelling index of either
BrdUR or 3H-TdR. However, the conditions (time, concen-
tration, temperature) of trypsin treatment after development
of autoradiographies were very critical.
Estimation ofLI and Ts
Flow cytometry The labelling index was obtained from cell
numbers found in two windows placed around the FITC-
labelled cells and total cells in cytogrammes of green vs red
fluorescence (Begg et al., 1985). The distinction between
labelled and unlabelled cells was clear cut in these experi-
mental tumours, with small differences in window placements
having little or no influence on the estimated LI. At times
longer than TG2, two separate labelled subpopulations were
visible, representing undivided and divided cells. In this case,
the number of divided cells (at the G, position) were divided
by two when calculating the LI (Begg et al., 1985). Since it
has been shown that unlabelled G2 cells have very little effect
on the overall LI, they were not taken into account (Begg et
al., 1989). Both the tumours were aneuploid with DNA
indices of approximately 1.7. Few labelled cells were seen
above the diploid peak. The windows were placed around the
aneuploid tumour population only. Ts was calculated by first
estimating the parameter Relative Movement (RM) using a
window placed around the undivided labelled cells and
measuring their position relative to G, cells (Begg et al.,
1985). T, was then calculated according to the equation:
Ts = 0.5 x t/(RM-0.5),
where t is the time between BrdUrd injection and tumour
excision. Again, only the aneuploid population was
included.
Histology The transit of cells through S-phase was followed
by sequential application of3H-TdR and BrdUrd at intervals
of 1-8 h. Tumours were excised and fixed 1 h after applica- tion of the second label. In histological sections the propor- tions of unlabelled, BrdUrd-labelled, 3H-TdR-labelled and
double labelled tumour cell nuclei were determined. Tumour
cell nuclei were relatively large and pale and in most cases
could readily be distinguished from endothelial cells, fibrob-
lasts or other host cells. For each labelling interval three
tumours were studied, from each tumour a total of 6000-
17,500 nuclei were counted from 2-4 sections. The labelling index (LI) was determined as percentage of BrdUrd positive nuclei of all counted nuclei.
With increasing time interval between injections, the pro- portion of nuclei labelled with BrdUrd but without 3H-TdR
vs all BrdUrd labelled nuclei increases (Figure 4). If we
denote this proportion with p, the time interval between the
two labels with t, and with Ts that point in time when p reaches 1 (100%), this can be expressed as
0 t 0
p = Bt for 0<t<T,
1 t>TS9
This implies that for values of t between 0 and Ts, the
equation relating p and t is a straight line starting at the
origin. For values > Ts, p equals I (100%). From the fact
that two sections of the relation must meet at t = T, one can
derive the continuity condition
T = I/i.
The parameters 3 and T, and their standard errors were
determined by nonlinear regression techniques (Seber &
Wild, 1989). The computer programme used was BMDPAR
(Dixon et al., 1990). The aim of the experiment was rather to
compare different groups of tumours within this study than
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to correct for the nonlinear age distribution of proliferating
cells. Since for tumours of quite different growth and cell
kinetic characteristics very similar values of A were cal-
culated, there is no reason to assume that the age distribution
of the tumours in the present study should be different from
each other (Wilson et al., 1992).
Results
Labelling index
In AT84 as well as in AT478/25 tumours of 100 mg size,
comparison of in vitro or in vivo application of BrdUrd and
detection by FCM of IHC, did not reveal any significant or
systematic differences in LI. (Table I). No consistent trend
was seen between in vitro vs in vivo LI, or between histology
vs FCM LI. The overall average LIs were 22.8% and 22.1%
in AT84 and AT478/25 respectively.
S-phase duration
When DNA precursors were given in vivo, the T, values
derived from histological evaluation and from flow cytometry
were similar (Table I). However, when double labelling with
3H-TdR and BrdUrd was attempted in vitro, the second label
was not incorporated when intervals exceeded 1 h. Similarly,
there was no relative movement of labelled cells in tumours
which were incubated in BrdUrd-free medium under hyper-
baric oxygen conditions for 1-4 h after in vitro labelling with
either 5011M or 1 lM BrdUrd (Figure 1). For this reason,
only in vivo T, estimates are included in Table I. The
estimates of Ts in vivo from FCM (Relative Movement
method) and IHC (double labelling method) were in good
agreement.
In order to investigate the reason for this failure of cells to
proceed through the cell cycle in vitro, tumour slices were
re-incubated in medium at 37°C under hyperbaric oxygen
conditions for time periods up to 6 h, before labelling with
50AM BrdUrd. The LI determined histologically decreased
continuously after pre-incubation times of more than 3 h
(Figure 2a). In contrast, the LI determined by FCM was
unchanged throughout the experiment (Figure 2b). However,
the fluorescence intensity of labelled nuclei, a measure of the
DNA synthesis rate, decreased dramatically with increasing
pre-incubation periods (Figure 2c). This indicates a much
higher sensitivity of BrdUrd detection by FCM as compared
to IHC. When growth factors were added to the medium
during the pre-incubation period in the form of 10% foetal
calf serum, a similar decrease in DNA synthesis rate was
observed.
Influence of tumour size andgrowth rate on Tot
Volume doubling times Td as well as potential doubling
times Tpot of AT84/4 and AT478/25 were very similar in
100 mg tumours (Table II). With increasing tumour size
(600 mg) however, there was a more pronounced reduction in
tumour growth in AT84 as compared to AT478/25. The
early, more slowly growing generation of AT478 showed
much longer Td and Tpot in small tumours but only a very
moderate increase in both parameters with tumour size. The
cell loss factor was greater in this tumour than in the two
fast growing tumours.
A separate analysis of the two components of Tpot, LI and
T, revealed that the size related increase in Tpot in AT84 and
AT478/25 was due to both a reduction of LI and a
significant protraction of T,. Comparison of the fast and the
slowly growing passage of AT478 shows, that the T. in the
two tumour generations was comparable while the LI of
AT478/4 was very low at 100 mg and fully accounts for the
observed prolongation in Tpo
Intratumour variability ofT,
All three tumours investigated roughly displayed a similar
spatial pattern ofproliferation. The tumour periphery usually
showed a high density of labelled nuclei, bordering on a zone
of viable, but less actively proliferating tumour tissue which
was surrounding central areas of necrosis. Necrotic areas
were minimal in small, i.e. 100 mg tumours and quite exten-
sive in large, i.e. 600 mg tumours. Although this arrangement
was predominant, there were occasionally necrotic areas close
to the tumour capsule or chords of viable tumour tissue
extending into necrotic areas. Within viable areas three
different labelling patterns could be distinguished and could
often be observed in one and the same tumour section: There
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Figure 1 Relative Movement as a function of time interval after
in vivo (circles) or in vitro (triangles) labelling of AT84 (a) and
AT478/25 (b). Plotted are mean values of three tumours per interval ± s.d.
Table I Comparison of different techniques of labelling and detecting cells in S-phase.
Values of LI represent means ± s.e.m., n = 9; T, estimates were obtained as described;
deviations are given as s.e.m.
AT84 AT84 AT478/25 AT478/25
FCM histology FCM histology
LI in vivo (%) 27.8 ± 7.2 22.2 ± 0.9 19.1 ± 1.4 23.9 ± 0.8
LI in vitro (%) 22.3 ± 1.0 19.3 ± 0.5 21.4± 1.1 24.1 ± 0.8
T, in vivo (h) 10.95 ± 0.57 10.9 ± 0.8 9.86 ± 0.89 10.1 ± 0.4
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a were areas where proliferating cells appeared to be randomly
distributed (Figure 3a). Often, tumour cells were arranged in
cell nests, which were surround by blood vessels and which
showed actively proliferating cells in their outer cell layers
(Figure 3b). On the other hand, chords of tumour cells
surrounding a supporting blood vessel with maximum pro-
liferative activity in their centre could also be found (Figure
3c). In the more slowly growing AT478/4, the two latter
patterns were predominant, while in fast growing tumours
AT478/25 and AT84, and especially in the tumour periphery
of small tumours, a random staining pattern prevailed.
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Figure 2 Effect of pre-incubation of tumour slices in medium at
37°C and under hyperbaric oxygen conditions for time periods up
to 6 h on the BrdUrd labelling index. Each symbol represents the
mean value ± s.d. of three tumours. a, Histological BrdUrd LI as
a function of the length of time of pre-incubation. b, FCM
BrdUrd LI as a function of the length of time of pre-incubation.
c, Fluorescence intensity of BrdUrd positive nuclei in FCM as a
function of the length of time of pre-incubation.
c
Figure 3 Photomicrograph of murine scc's, after in vivo double
labelling with 3H-TdR and BrdUrd at I h interval. 3H-TdR is
detected by autoradiography (black silver grains), while BrdUrd
is visualised by APAAP immunohistochemistry (bright red
nuclear staining). a, Peripheral area of At84, showing a random
distribution of labelled nuclei. Most labelled nuclei are positive
for both markers. Only occasional nuclei are positive for only
3H-TdR (arrow) or BrdUrd (double arrow). The line represents
501tm. b, Marginally labelled tumour cell nest of AT478/25. The
line represents 1001 m. c, Labelled tumour cells surrounding a
blood vessel, AT478/25. The line represents 100lim.
Table 11 Cell kinetic and tumour growth parameters for small and large tumours of each tumour line
AT84/4 AT478/25 AT478/4
100 mg 600 mg 100 mg 600 mg 100 mg 600mg
Td (95% c.l.) (d) 2.6 (2.2-3.2) 15.1 (10-30) 2.7 (2.3-3.1) 11 (7.7-17) 6.4 (5.9-7.1) 19.5 (14-33)
Tpot (d) 2.0 5.2 1.8 3.5 3.6 4.7
LIs ± s.e.m. (%) 22.2 ± 0.9 13.9 ± 0.4 23.9 ± 0.9 14.6 ± 0.9 11.7 ± 0.8 11.23 ± 0.7
T, ± s.e.m. (h) 10.8 ± 0.8 17.4 ± 0.9 10.1 ± 0.4 12.4 ± 2.4 10.0 ± 0.2 12.6 ± 0.6
cell loss (%) 23 65.6 33.3 67.3 43.8 75.9
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In AT478/25 tumours, the actively proliferating tumour
periphery was analysed separately from the more quiescent,
but still viable central areas in order to quantitate regional
differences in Tpot In the periphery, the labelling index was
35% and a Ts of 10 h was estimated, while in the centre the
LI dropped to 10.8% and Ts increased to 22.5 h. Thus,
within one tumour, different local values of values ranging
from 1 to 7 days can be calculated (Figure 4). In terms of
three-dimensional tissue volumes however, the quiescent
tumour centre (Figure 4b) represents only a very minor
proportion of the tumour volume. Since the LI is low in the
tumour centre, this cell population is relatively under-
represented in an overall analysis of tumour T, (Table I),
taking only labelled nuclei into account.
studies of Parkins et al. (1991), where unlabelled stromal cells
could not readily be distinguished from diploid tumour cells,
leading to an underestimate of LI by FCM. Aneuploid
human tumour cells labelled in vitro with BrdUrd were also
found to have a higher LI in the study of Gasinska et al.
(1989), although a good correlation was found for LI
between the FCM and IHC methods when all cells were
included with both methods. These data suggest that there is
little difference in the ability to discriminate between labelled
and unlabelled cells by the two techniques, although LI for
diploid tumours may be underestimated by FCM, and pos-
sibly for IHC if a morphological distinction between normal
and malignant cells is difficult.
Discussion
This study provides several comparisons of techniques to
measure cell proliferation kinetics in tumours. These com-
parisons will be discussed in turn, followed by some con-
clusions and recommendations.
Flow cytometry vs immunohistochemistry
LI and T, values obtained on the same tumours by FCM and
IHC were in good agreement. The tumours studied were both
aneuploid so that flow cytometric distinction between tumour
and host cells could be made based on DNA content. The
DNA index of both tumours was approximately 1.7, so that
an overlap was possible between normal G2 cells and tumour
GI and S-phase cells. Few if any labelled cells were seen in
the unequivocally normal cell population, however, so that
any inaccuracies in LI due to population overlap are likely to
be small. This was not the case in the clinical studies of
Bennet and colleagues (1992), or in the human xenograft
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Figure 4 Separate analysis of T, in the periphery (a) and centre
(b) of 600 mg AT478/25. With increasing time interval between
application of 3H-TdR and BrdUrd, the proportion of nuclei
labelled for BrdUrd only in relationship to all labelled nuclei
increases. T, estimates were 10.3 ± 0.26 h in the periphery and
22.5 in the centre, while corresponding LI values were 35.1 ± 4.1%
and 10.8 ± 1.7% respectively. Symbols represent single
tumours.
3H-TdR vs BrdUrd
Comparison of LIs obtained after labelling with 3H-TdR or
BrdUrd has yielded a good correlation in some studies
(Meyer et al., 1989; Wilson et al., 1985), while other authors
reported a greater sensitivity of the BrdUrd technique
(Knapp, 1992). In the present study, no difference between
3H-TdR and BrdUrd LI values were seen, indicating the
equivalence of the two techniques in our hands. Simul-
taneous application of 3H-TdR and BrdUrd in vivo, however,
was reported to require an increase in either 3H-TdR dose or
autoradiographic exposure time in order to obtain a constant
3H-TdR LI (Hume & Thompson, 1989), while the BrdUrd LI
was the same in single and double labelling experiments. In
order to prevent a possible inhibition of 3H-TdR uptake by
BrdUrd, 3H-TdR was always given prior to BrdUrd in the
present study. Since there was no systematic or significant
difference in 3H-TdR and BrdUrd LIs in double labelling
experiments, an interaction between these two precursors
appears to have been insignificant.
Can T, ofexplants be measured in vitro?
One goal of the study was to assess the feasibility of
estimating Ts after in vitro labelling of tumour biopsies, thus
circumventing the necessity of systemic application of DNA
precursors in patients. Although LI values were not altered
by pre-incubation of tumour slices for up to 3 h at 37°C and
much longer time periods at lower temperatures, neither
double labelling nor progression through the cycle measured
by flow cytometry could be achieved. This could not be
modified by hyperbaric oxygen, reduction of precursor con-
centrations to non-toxic levels or the addition of extra
growth factors in the form of foetal calf serum. Similar
difficulties had been encountered using radioactive labelling
techniques, as summarised by Steel (1977). Tumour cells with
a DNA content between GI and G2 but negative for BrdUrd
have been described in several studies (de Fazio et al., 1987;
Wilson et al., 1985). In addition, S-phase arrest can be
induced in leukaemia cells by incubation with ARA-C, IFN
or an IL-1 receptor antagonist (Preisler et al., 1992). How-
ever, S-phase arrest is not a usual physiological mechanism
of cell cycle control but probably occurred in these
experiments because of the in vitro conditions. It is not clear
how this can be circumvented, although other oxygenation
conditions, incubation times and/or growth factors need to
be tested. We conclude that a purely in vitro estimation ofTs
by relative movement or double labelling is impossible using
standard techniques.
Is measurement methods: single vs double labelling
The double labelling technique used in the present study for
histological assessment of Ts combines 3H-TdR autoradio-
graphy with BrdUrd IHC, as suggested by Hamada (1985). It
is based on quantifying the proportion of cells exiting or
entering S-phase during the interval between labels and thus
containing only one label rather than two (Wimber & Quast-
ler, 1963). Double labelling can also be performed using two
different radioisotopes to label thymidine, which can then be
deteced in different layers of autographic emulsion (Schultze
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et al., 1976). Alternatively, non-radioactive techniques have
been developed using two different thymidine analogues
which can be recognised by specific antibodies. However,
cross-reactivity of these antibodies could be a problem in
both IHC methods (Shibui et al., 1989; Hoshino et al., 1986)
and FCM (Bakker et al., 1989; Raza, 1987). Furthermore,
histological distinction between bound antibodies, i.e. the
distinction of unlabelled, single or double labelled nuclei is
entirely based on a visual distinction of colours, which could
be problematic, e.g. in nuclei labelled strongly with one label
and weakly with the other. These difficulties can be avoided
by combining 3H-TdR autoradiography with BrdUrd IHC.
The risk of confusing the two labels or ofmistaking a double
labelled for a singly labelled nucleus is minimal when one
precursor is recognised by red staining in the section plane
and the other by silver grains in the photographic emulsion
above the section (Figure 3a). T. estimates have also been
derived from quantitative analysis of nuclear uptake of one
single radioactive DNA precursor (Dormer, 1973). However,
this requires analysis of the whole nucleus, which is only
possible in cell smears.
In this study, the T, values measured by FCM, using a
single analog and the Relative Movement method, were
insignificantly different from those measured by the double
label IHC/autoradiography technique (Table I). The present
technique using a combination of IHC and autoradiography
could also be applied to clinical material. In vivo labelling
with BrdUrd could be followed by in vitro labelling with
3H-TdR, provided that tumour exision is delayed for several
hours, until a time interval suitable for measurement of cell
cycle progression has elapsed and in vitro incubation can be
performed immediately after surgery. In addition to the
advantages mentioned above, this would mean that admini-
stration to the patient of two labels could be avoided. How-
ever, neither this or other studies have yet shown that double
labelling has advantages over the FCM single labelling
method.
Tumour size dependence
Comparison of small, i.e. 100 mg and large, i.e. 600 mg
tumours showed a significant increase in T. with tumour size.
While small tumours had little of no necrosis, large tumours
had developed fairly extensive areas of necrosis which were
presumably surrounded by a zone ofhypoxic but viable cells.
Since a retarding effect of hypoxia on cycle progression has
been observed both in vitro (Born et al., 1976) and in vivo
(Shrieve & Begg, 1985), the tumour size related increase in T,
may be due to increased tumour hypoxia. When tested func-
tionally however, the time course of repopulation was found
identical in small and large AT478 tumours (Kummermehr,
1993).
The LI and Ts values obtained in the present study are
longer than in most other reports on experimental tumours
(reviewed by Denekamp, 1970 and by Steele, 1977; Carlton et
al., 1991). However, both tumour lines investigated in the
present study were fairly well differentiated and slowly grow-
ing. Although the LI values reported here are higher than in
most human tumours (Meyer & He, 1993), they are lower
than in the majority of experimental tumours described
(Denekamp, 1970 and Steele, 1968). A fast, late passage and
a slow, early generation of one tumour line differed in LI,
growth fraction and cell loss factor, but not in Ts.
Regional variations in LI and T7
In human head and neck squamous cell carcinomas, Bennett
et al. (1992) described histological patterns ofproliferation of
tumour cell nests as either marginal, intermediate or random,
with considerable local variation of LI. The present study
shows that not only the LI but also the Ts is subject to
considerable regional variation within one tumour, ranging
from 10-22.5 h. The values ofT., LI and Tpot thus represent
overall means which are composed of a wide range of local
values. However, the scale at which these extremes are being
observed is rather small and should be below an average
sized clinical tumour biopsy. This is in good agreement with
the finding of a moderate to low intratumoural variability
when several biopsies from one human tumour were com-
pared (Begg et al., 1988; Wilson et al., 1988; Bennett et al.,
1992). Begg et al. (1988) reported that the variability in LI
was considerably greater than that for Ts in multiple biopsies
taken from human tumours. This was not the case in our
comparison of tumour periphery and centre, where both
parameters changed by a factor of about two within a few
millimeters. It therefore appears likely that the spatial resolu-
tion of comparing whole biopsies is not sufficient to detect
regional variations in Ts.
Assuming that variations in Tt comparable to those
observed in murine squamous cell carcinomas occur in
human tumours, the important question would be which of
these regional Tpot values is the clinically relevant predictor of
tumour repopulation during radiotherapy? The shortest
values may approximate the maximum proliferative capacity
of a tumour, while the longer values may be associated with
hypoxia. Systematic performance of histological studies in
conjunction with FCM, estimating the regional minimum
and maximum Tpot in pre-treatment biopsies of human
tumours could answer this question and could possibly in-
crease the predictive power of overall Tpot measurements by
FCM.
In summary, it appears in general that FCM and IHC
methods give similar results for both LI and Ts. For
laboratories without access to flow cytometers, IHC tech-
niques are therefore clearly a good alternative for cell kinetic
studies. FCM has the advantage of speed, however, and
would be preferred if both systems are available. The big
advantage of the IHC remains that morphological and posi-
tional information is retained. This could be a crucial advan-
tage in diploid tumours for example, unlike those studied
here, where no distinction can be made between tumour and
normal cells on the basis of DNA content. FCM is only
adequate in these situations if separate tumour markers can
be measured simultaneously (Begg & Hofland, 1991;
Raemakers et al., 1986). Intratumoural variability can also
better be studied with IHC techniques where only a gross
estimate can be made with FCM. Finally, the present results
suggest that T, cannot be accurately measured in fresh
tumour explants by in vitro labelling, either by FCM or IHC
methods. Therefore for patient studies requiring T, estimates,
in vivo labelling remains the only choice at present.
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